Literature DB >> 19521993

Combined use of Impella device and intra-aortic balloon pump to improve survival in a patient in profound cardiogenic shock post cardiac arrest.

Anjan Gupta1, Suhail Allaqaband, Tanvir Bajwa.   

Abstract

Patients who suffer cardiogenic shock after cardiac arrest have a very poor prognosis. Left ventricular assist devices have proven to be useful in these patients to improve survival. Recently introduced percutaneous assist devices are easier to use and can be inserted quickly in the catheterization laboratory. We describe a case where intra-aortic balloon pump by itself was not enough to provide hemodynamic support in a patient with cardiogenic shock after cardiac arrest. The Impella Recover LP 2.5 system (ABIOMED, Inc., Danvers, MA) was successfully used along with the balloon pump for hemodynamic support and resulted in dramatic improvement of the patient's condition. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521993     DOI: 10.1002/ccd.22140

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Use of impella ventricular assist device in patients with severe coronary artery disease presenting with cardiac arrest.

Authors:  Venkata K Mukku; Qiangjun Cai; Syed Gilani; Ken Fujise; Alejandro Barbagelata
Journal:  Int J Angiol       Date:  2012-09

2.  Percutaneous Hemodynamic Support (Impella) in Patients with Advanced Heart Failure and/or Cardiogenic Shock Not Eligible to PROTECT II Trial.

Authors:  Wei Liu; Venkata Kishore Mukku; Syed Gilani; Ken Fujise; Alejandro Barbagelata
Journal:  Int J Angiol       Date:  2013-12

3.  Intensive care unit mortality after cardiac arrest: the relative contribution of shock and brain injury in a large cohort.

Authors:  Virginie Lemiale; Florence Dumas; Nicolas Mongardon; Olivier Giovanetti; Julien Charpentier; Jean-Daniel Chiche; Pierre Carli; Jean-Paul Mira; Jerry Nolan; Alain Cariou
Journal:  Intensive Care Med       Date:  2013-08-14       Impact factor: 17.440

4.  Percutaneous ventricular assist devices: new deus ex machina?

Authors:  Diego Arroyo; Stéphane Cook
Journal:  Minim Invasive Surg       Date:  2011-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.